This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
SEE YOU NEXT YEAR: May 7-10, 2023 | In-Person + Digital
San Diego, CA, USA

Joy Zeng, PhD
Associate Director, Analytical Development at Alnylam Pharmaceuticals


Joy Zeng, associate director of Alnylam Process and Analytical Science department in the area of starting material of siRNA. Graduated from University of California Riverside Analytical Chemistry in 2007, postdoc at MIT from 2007 to 2011. Joined Alnylam CMC analytical department in 2011 and have been focused in the area of starting material of siRNA since 2018. Lead an analytical development group working on the early-stage starting material related projects and lead an early stage starting material cross-function team working on control strategy for starting materials used for early stage siRNA programs.

Agenda Sessions

  • Control Strategy for Starting Materials Used for Early Stage siRNA Programs